Voloshin, Tali
Kaynan, Noa
Davidi, Shiri
Porat, Yaara
Shteingauz, Anna
Schneiderman, Rosa S.
Zeevi, Einav
Munster, Mijal
Blat, Roni
Tempel Brami, Catherine
Cahal, Shay
Itzhaki, Aviran
Giladi, Moshe
Kirson, Eilon D.
Weinberg, Uri
Kinzel, Adrian
Palti, Yoram
Article History
Received: 3 September 2019
Accepted: 24 February 2020
First Online: 6 March 2020
Compliance with ethical standards
:
: We wish to disclose that TV, NK, SD, YP, AS, MM, RSS, CTB, EZ, RB, SC, AI, MG, EDK, AK, and UW are employees of Novocure and hold stock in Novocure Ltd. Yoram Palti holds stocks in Novocure Ltd. Novocure holds several patents related to TTFields. The authors declare that there are no other conflict of interest.
: All procedures performed in this study involving mice were in accordance with the TechnionāIsrael Institute of Technology guidelines for the care of laboratory animals. Novocure Institutional Animal Care and Use Committee (Permits Number 21015 and 160816) and the Israel national committee (Permits Number IL-17-3-131 and IL-19-1-38) approved this study.
: C57Bl/6 and Balb/c mice used in this study were purchased from Envigo, Jerusalem, Israel.
: LLC-1 (Lot #70012223 and 58078573), CT-26 (Lot #58494154), HEPG2 (HB-8065, Lot #58987012), and H520 (HTB-182, Lot #59058814) cell lines were obtained from the American Type Culture Collection (ATCC). MOSE-L were kindly provided by Prof. Paul C. Roberts, Virginia Tech [CitationRef removed]. Phenotype was checked and was not changed over time.